arrow
T

Tatsushi Toda

the university of tokyo
H指数:67
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identifying facility-level and infrastructure-level bottlenecks in Japan's lecanemab rollout through an online survey of dementia specialists

通过在线调查痴呆症专家识别日本 Lecanemab 推广中的设施级和基础设施级瓶颈

2026-07-250
PRE
Soluble high-molecular-weight amyloid-β species derived from amyloid-β-laden brains induce cerebral β-amyloidosis

可溶性高分子量淀粉样蛋白-β物种源自淀粉样蛋白-β富集的大脑并诱导脑β-淀粉样蛋白沉积症

2026-07-200
OA
Vanishing White Matter Disease With EIF2B2 c.254T>A Variant: Mild Clinical and MRI Findings (vol 11, e200293, 2025)

范ishing white matter disease with EIF2B2 c.254T>A variant: 轻度临床和MRI表现 (vol 11, e200293, 2025)

2025-12-010
PRE
Novel in-frame duplication variant of SOD1 in a Japanese family with familial amyotrophic lateral sclerosis

一个日本家族性肌萎缩侧索硬化症中SOD1基因的新型框内重复变异

2025-12-010
PREAI
A Novel Transcriptional Slippage Mechanism Rescues Dystrophin Expression from a DMD Frameshift Variant

一种新型的转录滑动机制可拯救杜氏肌营养不良症框移变异的肌营养不良蛋白表达

2025-11-010
OAAI
A Novel Neuropathological Subtype of Amyotrophic Lateral Sclerosis Characterised by Prominent Astroglial TDP-43 Pathology

一种新型运动神经元病神经病理亚型,其特征是明显的星形胶质细胞TDP-43病理表现

2025-09-100
OAAI
Clinicopathological features of anti-HMGCR and anti-SRP myopathies that do not satisfy the EULAR/ACR criteria of inflammatory myopathies

抗HMGCR和抗SRP肌病的临床病理特征,这些肌病不符合EULAR/ACR炎症性肌病诊断标准

2025-04-030
PRE